- Annual Meeting
- Practice Resources
- Study Groups
- ISOO – Oral Oncology
MASCC Hemostasis Study Group
Study Group Minutes
Mission and Goals
The mission of the Hemostasis Study Group is to provide guidance and guidelines to healthcare providers regarding bleeding and clotting complications in cancer patients from diagnosis to the end of life. The goals of the group are (1) an increased awareness of abnormalities in the coagulation system at the time of cancer diagnosis, through treatment, and at the end of life, and (2) an increased availability of evidence-based treatment to patients with bleeding or clotting complications during treatment and at the end of life. To these ends, the Group has set the following objectives:
Romiplostim for the Management of Chemotherapy-Induced Thrombocytopenia
Outpatient Management of Pulmonary Embolism in Cancer
2017 Annual Meeting Workshop, June 22, Washington, DC
This workshop will be offered jointly by the following MASCC Study Groups: Education; Hemostasis.
Font C, Fernández-Avilés F, Calderon C, García-Fernández T, Arab N, Pineda E, et al. Home management of acute medical complications in cancer patients: a prospective pilot study. Support Care Cancer 2016 May;24(5):2129-37.
Fernandez-Martinez A, Font C, Selvi M, Viladot M, Paré L, Galván P. et al. Phlegmasia cerulea dolens and multiple recurrent thrombotic events as the presenting feature of EML4-ALK translocated non-small cell lung cancer. Cancer Treatment Communications, Feb, 2016.
Tancabelic J. “Recombinant Human Erythropoietin in Pediatric Cancer Patients.” Anemia During Cancer Workshop. Copenhagen, June, 2015.
Carmona-Bayonas A, Jiménez-Fonseca P, Virizuela Echaburu J, Antonio M, Font C, Biosca M, et al. Prediction of serious complications in patients with seemingly stable febrile neutropenia: Validation of the Clinical Index of Stable Febrile Neutropenia in a prospective cohort of patients from the FINITE study. J Clin Oncol. 2015 Feb 10;33(5):465-71.
Font C, Carmona-Bayonas A, Plasencia JM, Calvo-Temprano D, Sánchez M, Jiménez-Fonseca P, Beato C, Biosca M, Vicente V, Otero R; en representación de los Investigadores del Proyecto EPIPHANY. [Pulmonary embolism in patients with cancer: foundations of the EPIPHANY study] Med Clin (Barc). 2015 Jan;144 Suppl 1:31-7. Spanish.
Muñoz Martín AJ, Font Puig C, Navarro Martín LM, Borrega García P, Martín Jiménez M; Spanish Society for Medical Oncology. Clinical guide SEOM on venous thromboembolism in cancer patients. Clin Transl Oncol. 2014 Dec;16(12):1079-90.
Carmona-Bayonas A, Fonseca PJ, Font C, Martínez-García J, Torrella F, Urrego E, et al. Bacteremia in adult cancer patients with apparently stable febrile neutropenia: data from a cohort of 692 consecutive episodes from a single institution. J Community Support Oncol. 2014 Sep;12(9):312-20.
Parameswaran R, Lunning M, Mantha S, Devlin S, Hamilton A, Schwartz G, Soff G. Romiplostim for management of chemotherapy-induced thrombocytopenia. Support Care Cancer. 2014 May;22(5):1217-22.
Font C, Carmona-Bayonas A, Fernández-Martinez A, Beato C, Vargas A, Gascon P, Otero R. Outpatient management of pulmonary embolism in cancer: Data on a prospective cohort of 138 consecutive patients. J Natl Compr Canc Netw. 2014 Mar 1;12(3).
Carmona-Bayonas A, Font C, de la Peña FA. Stress-induced hyperglycemia is a valuable biomarker in febrile neutropenia. Rev Bras Hematol Hemoter. 2013;35(1):12-4.
Parameswaran R, Tancabelic J. An International Healthcare Provider Survey of Venous Thromboembolism Prophylaxis Guidelines Awareness in Cancer. Oral Presentation, MASCC Meeting New York, June 2012.
Font C, Farrús B, Vidal L, Caralt TM, Visa L, Mellado B, et al. Incidental versus symptomatic venous thrombosis in cancer: a prospective observational study of 340 consecutive patients. Ann Oncol. 2011 Sep;22(9):2101-6.
Font C, Vidal L, Espinosa G, Tàssies D, Monteagudo J, Farrús B, et al. Solid cancer, antiphospholipid antibodies, and venous thromboembolism. Autoimmun Rev. 2011 Feb;10(4):222-7.
What's New in the Management of Blood Clots for Cancer Patients
Please contact the Study Group Chairs above with your questions.